Patient-centered outcomes in the acute treatment of migraine: a prospective, real-world, longitudinal survey study (UNIVERSE II) comparing migraine patients who switch from a prior triptan to another triptan or ubrogepant
This real-world study demonstrated people with migraine who switched from a triptan to ubrogepant reported better outcomes than those who switched to a different triptan.
Authors
- Krutika Jariwala‐Parikh
- Pranav Gandhi (ORCID: https://orcid.org/0009-0008-8317-7712)
- Amit Bodhani (ORCID: https://orcid.org/0000-0001-5934-8413)
- François Cadiou
- Lauren E. Wilson (ORCID: https://orcid.org/0000-0002-5953-2293)
- Xingyu Gao (ORCID: https://orcid.org/0000-0002-5715-2078)
- Molly Duan
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
Institutions
- Albert Einstein College of Medicine (US)
- AbbVie (United States) (US)
- Genesis Research Institute (JP)
Publication Details
- Journal
- Pain Management
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1080/17581869.2025.2585269
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00